Overexpression of SASH1 related to the decreased invasion ability of human glioma U251 cells

The Unliganded Glucocorticoid Receptor Positively Regulates the Tumor Suppressor Gene BRCA1 through GABP Beta

(2012) H. D. Ritter et al.   MOLECULAR CANCER RESEARCH

Alterations in PTEN and PIK3CA in colorectal cancers in the EPIC Norfolk study: associations with clinicopathological and dietary factors

(2011) Adam Naguib et al.   BMC CANCER

Biological functions of p53 isoforms through evolution: lessons from animal and cellular models

(2011) V Marcel et al.   CELL DEATH AND DIFFERENTIATION

MMP-9 induces CD44 cleavage and CD44 mediated cell migration in glioblastoma xenograft cells

(2011) Chandramu Chetty et al.   CELLULAR SIGNALLING

Neurosurgery for Brain Tumors: Update on Recent Technical Advances

(2011) Jonathan H. Sherman et al.   Current Neurology and Neuroscience Reports

Malignant Gliomas: Diagnosis and Treatment

(2011) Sherise D. Ferguson   DM DISEASE-A-MONTH

MDA-9/syntenin: a positive gatekeeper of melanoma metastasis

(2011) Swadesh et al.   Frontiers in Bioscience-Landmark

The candidate tumor suppressor SASH1 interacts with the actin cytoskeleton and stimulates cell–matrix adhesion

(2011) Melanie Martini et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Cytokine networks in glioma

(2011) Kenichiro Iwami et al.   NEUROSURGICAL REVIEW

JunB promotes cell invasion and angiogenesis in VHL-defective renal cell carcinoma

(2011) T Kanno et al.   ONCOGENE

Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours

(2011) N Rajan et al.   ONCOGENE

Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor α5β1 in the process

(2010) Triparna Sen et al.   EUROPEAN JOURNAL OF NUTRITION

Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas

(2010) Marc C Chamberlain   Expert Review of Neurotherapeutics

Molecular genetic and epigenetic analysis ofNCX2/SLC8A2at 19q13.3 in human gliomas

(2010) M. Qu et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Suppression of NF- B activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells

(2009) A. Kim et al.   CARCINOGENESIS

Gene Therapy for Brain Cancer: Combination Therapies Provide Enhanced Efficacy and Safety

(2009) Marianela Candolfi et al.   CURRENT GENE THERAPY

Acacetin, a flavonoid, inhibits the invasion and migration of human prostate cancer DU145 cells via inactivation of the p38 MAPK signaling pathway

(2009) Kun-Hung Shen et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Suppression of putative tumour suppressor geneGLTSCR2expression in human glioblastomas

(2008) Y-J Kim et al.   JOURNAL OF PATHOLOGY